ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Supramolecular Allostery Achieves Tunable Luminescence Aromatic Bridged Phenothiazine Noncovalent Frameworks.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Here, we report an engineering tunable luminescent supramolecular organic framework (SOF) enabled by multiple allosteric effects, composed of a tetracationic vinylphenylpyridinium-modified aromatic-bridged phenothiazine guest and cucurbit[8]uril in a 1:2 stoichiometric ratio, formed via non-covalent polymerization driven by strong host-guest cooperation. The nanofiber-like guest is activated to form a supramolecular network polymer with negligible luminescence at 815 nm, showing an ultra-large Stokes shift of up to 240 nm. Interestingly, under oxidant driving, the guest allosterically converts to phenothiazine sulfoxide, which makes the weakly luminescent SOF exhibit strong yellow fluorescence, and the emission blueshifts to 610 nm, with the quantum yield increasing 46-fold to 22.2%. Additionally, the dynamic reversibility of macrocyclic bonding endows the SOFs with reversible and dissociative allosteric properties, enabling thermos-reversible regulation of their luminescence and competitive guest-induced quenching performance. Finally, the allosterically controlled luminescent SOF has been successfully applied to information encryption and logic gates, providing a new perspective for developing intelligent supramolecular materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.